4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population
July 18, 2026 15:15 ET | Source: 4D Molecular Therapeutics, Inc. After…
4DMT Announces New Employment Inducement Grants
EMERYVILLE, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq:…
